Pharmacological modulation of [K+]. accumulation and action potential changes during acute myocardial ischemia is under evaluation as a promising new antiarrhythmic and cardioprotective strategy during myocardial ischemia and reperfusion. We studied the effects of cromakalim, a K' channel opener that activates ATP-sensitive K+ channels, in isolated arterially perfused rabbit interventricular septa subjected to ischemia and reperfusion and, through use of the patch clamp technique, in inside-out membrane patches excised from guinea pig ventricular myocytes. During aerobic perfusion, 5 ,uM cromakalim shortened action potential duration (APD) from 217±7 to 201±f10 msec, had no effect on [K+10, and reduced tension by 17±3% (n=11). During ischemia, pretreatment with 5 JLM cromakalim resulted in 1) more rapid APD shortening (71+9 versus 166±7 msec at 10 minutes and 63±f12 versus 122±8 msec at 30 minutes), 2) similar [K+J0 accumulation after 10 minutes (8.9+0.3 versus 9.6±0.5 mM) but a trend toward increased [K+1L accumulation after 30 minutes (11.0±+1.7 versus 9.6±+1.0 mM), and 3) similar times for tension to decline to 50o of control (2.14±0.16 versus 2.14±0.19 minutes) but shorter time to fall to 20%o of control (4.34±0.33 versus 4.90± 0.22 minutes; p=0.003). After 60 minutes of reperfusion following 30 minutes of ischemia, recovery of function was similar, with a trend toward better recovery of developed tension (to 58±9%o versus 39±10%o of control; p=0.18) and tissue ATP levels in cromakalimtreated hearts but no differences in APD or rest tension. Thus, 5 ,M cromakalim had mild effects in normal heart but greatly accelerated APD shortening during ischemia without markedly increasing [K'] accumulation, possibly because the more rapid APD shortening reduced the time-averaged driving force for K+ efflux through ATP-sensitive K' channels. A significant cardioprotective effect during 30 minutes of ischemia plus 60 minutes of reperfusion could not be demonstrated in this model. In excised membrane patches studied at room temperature, the ability of cromakalim to activate ATP-sensitive K' channels was significantly potentiated by 100 ,uM but not 15 ,uM cytosolic ADP, suggesting that in addition to the modest fall in cytosolic ATP during early ischemia, the rapid increases in cytosolic ADP may further sensitize cardiac ATP-sensitive K' channels to activation by cromakalim. This factor may contribute to the marked acceleration of APD shortening during ischemia produced by concentrations of cromakalim that have minimal effects on APD in aerobic perfused tissue. Activation of ATP-sensitive K+ channels by cromakalim was not significantly affected by other ischemic factors such as lactate (20 mM 
I ncreasing evidence suggests that activation of ATPsensitive K' (KAT) channels plays an important role in extracellular K+ concentration ([K+] o) accumulation and electrophysiological changes during early ischemia.1-5 The resulting cellular depolarization, slow conduction, and altered refractoriness are major factors predisposing the ischemic heart to lethal reentrant arrhythmias-the leading cause of death from coronary artery disease.6,7 However, whether activation nels may shorten the time window during which the ischemic heart is susceptible to ischemic arrhythmias. Also, the more rapid rate of action potential duration (APD) shortening and earlier onset of inexcitability has an energy-sparing effect by reducing contractile force were also studied through the use of patch-clamp techniques in excised membrane patches from guinea pig ventricular myocytes.
Materials and Methods Isolated Intact Heart Experiments
Preparation and experimental setup. New Zealand White rabbits of either sex (weight, 2-3 kg) were anesthetized with pentobarbital sodium after heparinization, and the hearts were removed through a thoractomy incision. The septal branch of the left coronary artery was cannulated, and interventricular septum was isolated and mounted in a nitrogen-filled chamber maintained at 37°C, as described previously.13 For tension measurements, a ligature placed at the apex of the septum was tied to a tension transducer. The hearts were paced at 75 beats per minute through a bipolar platinum electrode. Arterial perfusion was maintained at a rate of 1.75 ml/min at 37°C with a perfusion pump. Venous effluent samples were collected through polyethylene tubing anchored at the base of the septum. The arterial perfusate consisted of (mM) NaCl 120, KCl 4, CaCI2 1.5, NaHCO3 25, NaH2PO4 0.44, MgCl2 1, dextrose 5.6, and 10 units/l insulin. pH was maintained at 7.3-7.4 by gassing the perfusate with 5% CO2 and 95% 02. Total global ischemia was produced by turning off the perfusion pump. Each preparation was allowed to equilibrate for at least 1 hour before any experimental intervention.
Electrodes. Intracellular potential was monitored using floating glass microelectrodes filled with 3 M KCl.14 [K']. was monitored continuously with intramyocardial valinomycin K'-selective minielectrodes.13 K+-selective electrodes were calibrated in vitro before and after removal from the heart at 37°C in the standard arterial perfusate with different K+ concentrations (4, 8, 10 , and 12 mM with KCl replacing NaCl isotonically) and also in situ by transiently increasing the perfusate K+ concentration to 10 mM after insertion of the electrode in the muscle. The results were discarded if the slope per 10-fold change in K+ was less than 56 mV at 37°C or if the in situ response differed by more than 10% from that obtained during in vitro calibration. For convenience the results are reported in concentration rather than activity units, assuming the activity coefficient of the calibration solutions did not differ significantly from that of the extracellular fluid surrounding the tip of the K' electrode. The K' electrode was typically positioned with 2-3 mm of the floating microelectrode.
Metabolic assays. To measure the tissue high-energy phosphates the septum was quickly smash-frozen between copper tongs precooled in liquid N2 and then immersed in liquid N2. Tissue content of ATP, ADP, and AMP were determined by high-performance liquid chromatography from =200-mg tissue samples extracted with 3 M perchloric acid after pulverization. '5 The lactate content was determined by spectrophotometric techniques.15 Lactate content was measured in samples of venous effluent collected for 30-second intervals.
Isolated Ventricular Myocyte Experiments
Cell isolation. Guinea pigs (weight, 200-300 g) were anesthetized with pentobarbital sodium and the hearts removed through a thoracotomy incision. Hearts were mounted on a Langendorff perfusion apparatus, and enzymatic digestion was performed by retrograde perfusion of collagenase and protease through the aorta as described by Mitra and Morad. '6 Patch clamp methods. Cells were placed in a shallow, 0.5-ml capacity chamber mounted on the stage of an inverted microscope and were superfused at a rate of 1-4 ml/min with modified Tyrode's solution consisting of (mM) KCl+KOH 
Effects of Cromakalim During Prolonged Ischemia
Followed by Reperfusion
To assess the effects of cromakalim on recovery of function after a prolonged ischemic episode, hearts were subjected to a single 30-minute period of total global ischemia, either in the absence (n = 6) or presence (n=6) of a 10-minute pretreatment with 5 ,M cromakalim. Both groups were subsequently reperfused for 60 minutes in the absence of cromakalim to assess recovery of function ( Figure 3 ).
Effects during ischemia. As in the hearts subjected to 10 minutes of ischemia, cromakalim caused more rapid APD (Figure 7 ). However, a small additive effect (as seen in the example in Figure 6 (Figure 3 ). This may be related to the fact that the APD did not shorten much further during the last 20 minutes of ischemia in the cromakalimtreated hearts (Figure 3 In intact heart subjected to ischemia, most of the early decline in developed tension occurs before the APD has shortened significantly, and has been attributed primarily to altered responsiveness of the myofilaments to Ca21i by accumulation of intracellular Pi and H+, as well as mechanical factors related to collapse of the vascular space.36 APD shortening probably has a major effect on the decline of tension during hypoxia or ischemia only under conditions in which the consequences of altered myofilament responsiveness to Ca + are minimized, such as when unloaded shortening is used as an index of contractile performance in isolated myocytes subjected to hypoxia.37 This may explain why cromakalim did not significantly shorten the time required for developed tension to decline to 50% during ischemia, since the half-time for tension decline was less than 2 minutes, and even in the cromakalim-treated hearts APD had only shortened by o10% after 2.5 minutes of ischemia (Figure 2 ). However, cromakalim did modestly but significantly shorten the time for tension to fall to 20% during ischemia, presumably by accelerating the rate of APD shortening during the later phase of tension decline. 
